资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells

Oncotarget. 2017-04;

ZhuoZhihong, YuHu

Products/Services Used	Details	Operation
Catalog Antibody	… obtained from Invitrogen (Pontoise, France). Antibodies against LC3-II/I, PTEN, pAKT, pmTOR, beclin1 and GAPDH were purchased from Genscript Biotechnology (USA). Cell lines and culture conditions. A PR-EC sub-cell line …	Get A Quote

摘要

miR-205 is significantly up-regulated in endometrioid adenocarcinoma. In this study， the significant anticancer effect of a miR-205 inhibitor was investigated in both endometrial carcinoma and progesterone-resistant endometrial carcinoma cells.